Business Wire

Onomondo Launches Unique SoftSIM to Transform Internet of Things

Share

Getting an Internet of Things (IoT) project off the ground has historically looked something like this: you receive your IoT device, you choose a provider and a data plan, the provider or carrier sends you a SIM card, and you then insert your SIM into your device to connect to your provider. However, if you want to switch to a different provider, you’ll need to physically remove the SIM card from every device and repeat the same process with the new provider. For many IoT projects, particularly those in remote or isolated locations, this is a friction-filled process, often resulting in vendor lock-in, hindering the uptake and scaling of projects.

So-called “eSIMs” have grown in popularity in recent years to tackle this friction. Enabled by eUICC (Embedded Universal Integrated Circuit Card) standards, users can now load new carrier profiles digitally, over the air, eliminating the need to physically swap SIM cards. While this solution offers more flexibility than regular SIMs, the commercial agreements can be equally binding through bootstrapped network profiles, and hardware still needs to be installed into each device.

The Onomondo SoftSIM offers a new frictionless pathway. The SIM is downloaded from the cloud onto chipsets already found in devices which brings IoT time to deployment down to virtually zero. The Onomondo operator agnostic approach, which gives customers the ability to choose their network and exactly the type of service they need depending on the product they are tracking, means that customers don’t suffer from any hidden lock-ins or unnecessary costs. Making the SIM downloadable also means that customers only start paying to track their devices when they need to, rather than paying upfront for a SIM card and associated costs in connection to its installation. For users, this means lowering the bill of materials for companies rolling out IoT by between 50-90% depending on the scale of the fleet.

Onomondo has redesigned existing IoT connectivity architecture through integrating more than 700 operators at the Radio Access Network (RAN) level across more than 180 countries, as well as layering its own API-based IoT platform on top. With the new SoftSIM, as soon as the SIM is downloaded, assets can seamlessly move across national borders without the inherent complexity of roaming. Onomondo customers can also gain granular, real-time insight into the performance of each connected device, allowing them to tap into their global grid and troubleshoot IoT devices from anywhere. Data is transferred directly across the Onomondo virtual network to one of the firm’s cloud partners (Microsoft Azure, AWS, IBM Watson and more), so enterprises can easily understand what is going on between devices and the network, through to the core network, and on to the IoT cloud from a single interface.

Michael Karlsen, Co-Founder & CEO, and Henrik Aagaard, Co-Founder & CTO at Onomondo commented: “The move to a plug and play SIM card is the catalyst that IoT has needed to be deployed at scale and to start to reach its full potential. In terms of significance, we see the development of a downloadable SoftSIM as comparable to the impact that the Cloud had on the internet. By eliminating the requirement for a complex physical connection, it removes an important friction point as well as opening the door to a broad spectrum of people to bring true innovation and creativity to IoT as the customer needs develop. The SoftSIM will also make an important contribution to improving IoT sustainability, eradicating the need for billions of chips a year to be manufactured, transported and installed.”

Based on a Trusted Connectivity Alliance report, in 2021 SIM card production resulted in 560,000 tons of CO₂ emissions and 18,000 tons of plastic. SIM production is expected to grow rapidly as connected IoT devices are predicted to reach 27 billion by 2025. SoftSIM has the potential to reduce CO₂ emissions, while virtually eliminating the plastic and polymer waste resulting from SIM card production. Innovations like these are important steps for the ICT industry to meet its goal of reducing greenhouse gas emissions by 45% between 2020 and 2030.

Earlier this year Onomondo announced a new $21m growth investment led by Verdane, a leading growth equity investment firm that specialises in scaling digital consumer, software, and sustainable society businesses. Onomondo will leverage the new funds to drive growth and meet its planned projection of tripling its ARR in 2022 and 2023. The company also plans to scale its team from 50 to 100 over the next year, helping to expand its customer base, which currently includes the likes of Bosch, Carlsberg, and Maersk.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media contact:
Sarah Mulder
Fire on the Hill
Telephone: +44 7720401466
Email: smulder@fireoth.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 22:06:00 CEST | Press release

HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 14:30:00 CEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

HiddenA line styled icon from Orion Icon Library.Eye